July 17, 2017
Duesseldorf, July 17, 2017 — Gerresheimer will complete its product portfolio of prefillable syringes made of glass and plastics with an innovative, integrated,...
More July 13, 2017
Revenues in second quarter of 2017 down 2.2% to EUR 339.5m as expected Adjusted EBITDA margin 22.3%, versus 23.2% in prior-year quarter Slight increase in...
More April 26, 2017
Dividend increased for sixth time in succession to EUR 1.05 per share All shareholder representatives on Supervisory Board reelected Dr. Axel Herberg...
More April 06, 2017
Revenues down 5.4% in first quarter of 2017 to EUR 302.8m Adjusted EBITDA margin at 19.8%, as in prior year EBITDA leverage unchanged at 2.6 Guidance for...
More March 03, 2017
Duesseldorf, March 03, 2017 - Dr. Christian Fischer (53) will join the Management Board of Gerresheimer AG as an ordinary member on August 1, 2017 before taking...
More February 15, 2017
Proposed dividend of EUR 1.05 per share (2015: EUR 0.85 per share) marks an increase of 23.5% Revenues up 7.2% in financial year 2016 to EUR 1,375.5m ...
More October 06, 2016
Life Science Research Division to be sold, guidance adjusted accordingly; Revenues up 8.4% to EUR 373.1m; Adjusted EBITDA increased by 24.2% to EUR 84.4m; ...
More September 12, 2016
Gerresheimer and Chase Scientific Glass, Inc. are to sell their joint venture (51/49%) Kimble Chase to Duran Group, a portfolio company of One Equity Partners ...
More July 07, 2016
Revenues up 4.0% to EUR 370.5m Adjusted EBITDA rises 17.5% to EUR 84.7m Adjusted EBITDA margin climbs to 22.8% Adjusted earnings per share surpass...
More April 28, 2016
Dividend increased to EUR 0.85 per share Large majorities for resolution approving work of Management Board and Supervisory Board
More 